»¶Ó­µ½
ɽ¶«²¬Ô´»¯Ñ§ÓÐÏÞ¹«Ë¾

Ãâ·Ñ»áÔ±
ɽ¶«²¬Ô´»¯Ñ§ÓÐÏÞ¹«Ë¾
Öйú
Share
ÂôÌṩ
Ñ¡Ôñ  ºËÈ¡·½‰K   ºÍµã»÷   ѯÎÊÏÖÔÚ   »ò   ¼ÓÈëѯÎÊÀº×Ó   »ò   ·ÅÔÚ²úÆ·ºÏ»ï
Çå³ýÈ«²¿ - ȫѡ
ÏÔʾ¸öÏîĿÿҳ
ÏÔʾ:  ²úÆ·Õ¹Ìü -  ²úÆ·Ãûµ¥  | 
Ìæ¼Ó·ú
Ìæ¼Ó·ú

Ìæ¼Ó·ú:Tegafur
CAS:17902-23-7
¹æ¸ñ:CP2005/JP14
Íâ¹Û:°×É«·ÛÄ©
¼Û¸ñ£ºµçÒé
°ü×° £º25ǧ¿ËÖ½°åͰ
ÓÃ;£º¿¹Ö×ÁöÀàAnticancer series

¶àÎ÷ËûÈü
¶àÎ÷ËûÈü

¶àÎ÷ËûÈü:Docetaxel
CAS:114977-28-5
¹æ¸ñ:¾Ö°ä±ê×¼
Íâ¹Û:°×É«·ÛÄ©
°ü×°; ÂÁÌý»òÂÁ²­´ü
¿¹Ö×ÁöÀàAnticancer series

Äδﲬ
Äδﲬ

Ãû³Æ£ºÄδﲬ
CAS:95734-82-0
¹æ¸ñ:¾Ö°ä±ê×¼
Íâ¹Û:µ­»ÆÉ«·ÛÄ©
¼Û¸ñ£ºµçÒé
°ü×°£ºÂ ÁÌý»òÂÁ²­´ü
ÓÃ;£º¿¹Ö×ÁöÀàAnticancer series

ÒÀ²¬
ÒÀ²¬

Ãû³Æ£ºÒÀ²¬
CAS:146665-77-2
¹æ¸ñ:ÆóÒµ±ê×¼
Íâ¹Û:°×É«»òÀà°×É«·ÛÄ©
°ü×°£ºÂÁÌý»ò Á²­´ü
ÓÃ;£º¿¹Ö×ÁöÀàAnticancer series

°ÂɳÀû²¬
°ÂɳÀû²¬

²úÆ·Ãû³Æ£º°ÂɳÀû²¬
Ó¢ÎÄÃû³Æ£ºOxaliplatin
CAS#61825-94-3
¹æ¸ñ£ºEP5
ÓÃ;£º¿¹Ö× Áö Anticancer series
º¬Á¿£º¡µ99.84£¥
°ü×°£ºÂÁÌý»òÂÁ²­´ü
¼Û¸ñ£ºµçÒé
ÐÔ×´£º°×É«½á¾§·ÛÄ©
·Ö×Ó Ê½£....

˳²¬
˳²¬

²úÆ·Ãû³Æ£ºË³²¬
Ó¢ÎÄÃû³Æ£ºCisplatin
CAS#15663-27-1
¹æ¸ñ£ºUSP29/E P5
ÓÃ;£º¿¹Ö×ÁöAnticancer series
º¬Á¿£º¡µ99.81£¥
°ü×°£ºÂÁÌý»òÂÁ²­´ü
¼Û¸ñ£ºµçÒé
ÐÔ×´£º»ÆÉ«·ÛÄ©
·Ö×Óʽ£º Cl2(NH3)2Pt

±½»ÇËá°¢Çú¿â°·
±½»ÇËá°¢Çú¿â°·

²úÆ·Ãû³Æ£º±½»ÇËá°¢Çú¿â°·
Ó¢ÎÄÃû³Æ£ºAtracurium Besylate
CAS#96946-42-8
¹æ¸ñ£ºIn-house standards
ÓÃ;£ºÕòÍ´Âé×íÀàAnalgesics of anesthetics
º¬Á¿£º102.0%
°ü×°£ºÀ䲨±£´æ
¼Û¸ñ£ºµçÒé
ÐÔ×....

ÄáË÷µØÆ½
ÄáË÷µØÆ½

²úÆ·Ãû³Æ£ºÄáË÷µØÆ½
Ó¢ÎÄÃû³Æ£ºNisoldipine
CAS# 63675-72-9
¹æ¸ñ£ºÆóÒµ±ê×¼In house standard
ÓÃ;£º¿¹¸ßѪѹ
º¬Á¿£º¡µ99.50%
°ü×°£º25ǧ¿ËÖ½°åͰ
¼Û¸ñ£ºµçÒé
·Ö×Óʽ£ ºC20H24N2O6

¿¨²¬
¿¨²¬

²úÆ·Ãû³Æ£º¿¨²¬
Ó¢ÎÄÃû³Æ£ºCarboplatin
CAS#41575-94-4
¹æ¸ñ£ºUSP29/EP5
ÓÃ;£º¿¹ Ö×ÁöAnticancer series
º¬Á¿£º99.82£¥
°ü×°£ºÂÁÌý»òÂÁ²­´ü
¼Û¸ñ£ºµçÒé
ÐÔ×´£º°×É«½á¾§·ÛÄ©
·Ö×Óʽ £º....

Ñ¡Ôñ  ºËÈ¡·½‰K   ºÍµã»÷   ѯÎÊÏÖÔÚ   »ò   ¼ÓÈëѯÎÊÀº×Ó   »ò   ·ÅÔÚ²úÆ·ºÏ»ï
ÏÔʾ61-69¹²69 | µÚÒ»Ò³ | ÉÏÒ»Ò³ | 1 | 2 | 3 | 4 | ÏÂÒ»Ò³ | ǰҳ


Òª½¨Á¢Äã×Ô¼ºµÄ¹«Ë¾ÍøÕ¾£¿
Çëµã»÷ÕâÀ